Methyl 5-methylpyrimidine-2-carboxylate, 95.0%, 1g

2-Fluorobenzylmethylsulfone, 97.0%, 1g

2-Chloro-3-methoxypyridine, 99.00%, 5g

L-ASPARTIC ACID-15N, 95.0%, 250mg

Methyl 2-(4-formylphenyl)acetate, 98.0%, 100g

3-Chloro-4-morpholino-1,2,5-thiadiazole>98.0%(GC)25g

5-Methyl-6-(trifluoromethyl)-1H-indole, 95+%, 250mg

2-bromo-5H,6H,7H-pyrrolo[2,3-b]pyrazin-6-one, 95.0%, 5g

4-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid, 95.0%, 1g

[(2-methylpropyl)sulfanyl]methanimidamide hydrobromide, 95.0%, 1g

(Difluoromethyl)benzene, 97.0%, 100mg

GC capillary column ROTI®Cap-FFAP, 25 m, 0.53 mm, 1.00 µm, 1 Piece(s)

Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 99%, 250mg